1. Growth of doxorubicin‐resistant undifferentiated spindle‐cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase. Issue 4 (2nd January 2018) Authors: Igarashi, Kentaro; Li, Shukuan; Han, Qinghong; Tan, Yuying; Kawaguchi, Kei; Murakami, Takashi; Kiyuna, Tasuku; Miyake, Kentaro; Li, Yunfeng; Nelson, Scott D.; Dry, Sarah M.; Singh, Arun S.; Elliott, Irmina A.; Russell, Tara A.; Eckardt, Mark A.; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroak... Journal: Journal of cellular biochemistry Issue: Volume 119:Issue 4(2018) Page Start: 3537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. (28th September 2018) Authors: Kawaguchi, Kei; Miyake, Kentaro; Han, Qinghong; Li, Shukuan; Tan, Yuying; Igarashi, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Higuchi, Takashi; Oshiro, Hiromichi; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Bouvet, Michael; Singh, Shree Ram; Unno, Michiaki; Hoffman, Robert M. Journal: Cancer letters Issue: Volume 432(2018) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model. (1st November 2020) Authors: Yamamoto, Jun; Miyake, Kentaro; Han, Qinghong; Tan, Yuying; Inubushi, Sachiko; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Homma, Yuki; Matsuyama, Ryusei; Chawla, Sant P.; Bouvet, Michael; Singh, Shree Ram; Endo, Itaru; Hoffman, Robert M. Journal: Cancer letters Issue: Volume 492(2020) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma. (28th March 2018) Authors: Igarashi, Kentaro; Kawaguchi, Kei; Li, Shukuan; Han, Qinghong; Tan, Yuying; Murakami, Takashi; Kiyuna, Tasuku; Miyake, Kentaro; Miyake, Masuyo; Singh, Arun S.; Eckardt, Mark A.; Nelson, Scott D.; Russell, Tara A.; Dry, Sarah M.; Li, Yunfeng; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; M... Journal: Cancer letters Issue: Volume 417(2018) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer. Issue 7 (3rd April 2018) Authors: Kawaguchi, Kei; Miyake, Kentaro; Han, Qinghong; Li, Shukuan; Tan, Yuying; Igarashi, Kentaro; Lwin, Thinzar M.; Higuchi, Takashi; Kiyuna, Tasuku; Miyake, Masuyo; Oshiro, Hiromichi; Bouvet, Michael; Unno, Michiaki; Hoffman, Robert M. Journal: Cell cycle Issue: Volume 17:Issue 7(2018) Page Start: 868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention. Issue 3 (1st February 2018) Authors: Kawaguchi, Kei; Han, Qinghong; Li, Shukuan; Tan, Yuying; Igarashi, Kentaro; Kiyuna, Tasuku; Miyake, Kentaro; Miyake, Masuyo; Chmielowski, Bartosz; Nelson, Scott D.; Russell, Tara A.; Dry, Sarah M.; Li, Yunfeng; Singh, Arun S.; Eckardt, Mark A.; Unno, Michiaki; Eilber, Fritz C.; Hoffman, Robert M. Journal: Cell cycle Issue: Volume 17:Issue 3(2018) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model. Issue 1 (January 2021) Authors: Sugisawa, Norihiko; Yamamoto, Jun; Han, Qinghong; Tan, Yuying; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Hamada, Kazuyuki; Kawaguchi, Kei; Unno, Michiaki; Bouvet, Michael; Hoffman, Robert M. Journal: Pancreas Issue: Volume 50:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging. Issue 13 (2nd July 2016) Authors: Yano, Shuya; Takehara, Kiyoto; Zhao, Ming; Tan, Yuying; Han, Qinghong; Li, Shukuan; Bouvet, Michael; Fujiwara, Toshiyoshi; Hoffman, Robert M. Journal: Cell cycle Issue: Volume 15:Issue 13(2016) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic. Issue 6 (19th March 2018) Authors: Igarashi, Kentaro; Kawaguchi, Kei; Kiyuna, Tasuku; Miyake, Kentaro; Miyake, Masuyo; Li, Shukuan; Han, Qinghong; Tan, Yuying; Zhao, Ming; Li, Yunfeng; Nelson, Scott D.; Dry, Sarah M.; Singh, Arun S.; Elliott, Irmina A.; Russell, Tara A.; Eckardt, Mark A.; Yamamoto, Norio; Hayashi, Katsuhiro; Kimur... Journal: Cell cycle Issue: Volume 17:Issue 6(2018) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗